Post-covid muscle and joint syndrome: analysis of prevalence and clinical characteristics in the population of the North Caucasus federal district
V. O. Agranovich,
M. G. Gevandova,
A. A. Khripunova,
N. V. Agranovich,
A. B. Khodzhayan,
A. S. Anopchenko https://doi.org/10.21886/2712-8156-2026-7-1-87-96
Abstract
Objective: To analyze various clinical manifestations of post-COVID syndrome, with a focus on muscle and joint lesions, identified in the population of the North Caucasus Federal District following COVID-19.
Materials and methods: a cohort study was conducted on the clinical base of the Department of Polyclinic Therapy of the Stavropol State Medical University and among residents of the North Caucasus Federal District: Stavropol Territory, the Karachay-Cherkess Republic, the Kabardino-Balkarian Republic, the Republic of North Ossetia-Alania, and the Republic of Ingushetia. More than 1,500 people were surveyed, but only 864 questionnaires with complete responses from those with confirmed COVID-19 were included in the statistical analysis.
Results: An analysis of the development of post-COVID joint syndrome showed that joint and muscle pain was experienced by 43.4% of the surveyed residents of the North Caucasus Federal District, with the highest percentage in the age groups of under 25, 26-35, and over 66 years.
Conclusion: The conducted study demonstrates the need to examine patients with newly developed symptoms of musculoskeletal disorders and justifies the development of combined methods for treating post-COVID joint syndrome.
About the Authors
V. O. Agranovich
Stavropol State Medical University
Russian Federation
Russian Federation
Vladimir O. Agranovich, Assistant of the Department of Medical Rehabilitation
Stavropol
M. G. Gevandova
Stavropol State Medical University
Russian Federation
Russian Federation
Margarita G. Gevandova, Dr. Sci. (Med.), Associate Professor, Head of the Department of Biology
Stavropol
A. A. Khripunova
Stavropol State Medical University
Russian Federation
Russian Federation
Alesya A. Khripunova, Cand. Sci. (Med.), Associate Professor, Head of the Department of Information and Digital Technologies
Stavropol
N. V. Agranovich
Stavropol State Medical University
Russian Federation
Russian Federation
Nadezhda V. Agranovich, Dr. Sci. (Med.), Professor, Head of the Department of Outpatient Therapy
Stavropol
A. B. Khodzhayan
Stavropol State Medical University
Russian Federation
Russian Federation
Anna B. Khodzhayan, Dr. Sci. (Med.), Professor, First Vice-Rector – Vice-Rector for Academic Affairs
Stavropol
A. S. Anopchenko
Stavropol State Medical University
Russian Federation
Russian Federation
Alena S. Anopchenko, Cand. Sci. (Med.), Docent of the Department of Outpatient Therapy
Stavropol
References
1. O'Sullivan O. Long-term sequelae following previous coronavirus epidemics. Clin Med (Lond). 2021;21(1):e68-e70. DOI: 10.7861/clinmed.2020-0204
2. Maxwell E. Living with Covid19: A dynamic review of the evidence around ongoing Covid19 symptoms (often called Long Covid). 2020. DOI: 10.3310/themedreview_411691
3. Barinov A.N., Ahmedzhanova L.T., Mahinov K.A. Algoritmy diagnostiki i lecheniya nevropaticheskoj boli pri porazhenii perifericheskoj nervnoj sistemy. RMZh. 2016;(3):154–162. (In Russ.)
4. Nasonov E.L., Yakhno N.N., Karateev A.E., Alekseeva L.I., Barinov A.N., Barulin A.E., et al. General principles of treatment for musculoskeletal pain: interdisciplinary consensus. Rheumatology Science and Practice. 2016;54(3):247-265. (In Russ.) DOI: 10.14412/1995-4484-2016-247-265
5. Eccles R. Understanding the symptoms of the common cold and influenza. Lancet Infect Dis. 2005;5(11):718-725. DOI: 10.1016/S1473-3099(05)70270-X
6. Whitelaw C.C., Varacallo M. Transientsynovitis. In: StatPearls. Treasure Island (FL): StatPearls Publishing, 2021.
7. Kanmaniraja D, Le J, Hsu K, Lee JS, Mcclelland A, Slasky SE, et al. Review of COVID-19, part 2: Musculoskeletal and neuroimaging manifestations including vascular involvement of the aorta and extremities. Clin Imaging. 2021;79:300-313. DOI: 10.1016/j.clinimag.2021.08.003
8. Fernandez CE, Franz CK, Ko JH, Walter JM, Koralnik IJ, Ahlawat S, et al. Imaging Review of Peripheral Nerve Injuries in Patients with COVID-19. Radiology. 2021;298(3):E117-E130. DOI: 10.1148/radiol.2020203116
9. Akhmedzhanova L.T., Ostroumova T.M., Solokha O.A. Management of patients with pain syndromes associated with COVID-19. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2021;13(5):96-101. (In Russ.) DOI: 10.14412/2074-2711-2021-5-96-101
10. Karaarslan F, Demircioğlu Güneri F, Kardeş S. Postdischarge rheumatic and musculoskeletal symptoms following hospitalization for COVID-19: prospective follow-up by phone interviews. Rheumatol Int. 2021;41(7):1263-1271. DOI: 10.1007/s00296-021-04882-8
11. Abdullahi A, Candan SA, Abba MA, Bello AH, Alshehri MA, Afamefuna Victor E, et al. Neurological and Musculoskeletal Features of COVID-19: A Systematic Review and Meta-Analysis. Front Neurol. 2020;11:687. DOI: 10.3389/fneur.2020.00687
12. Zhou Y, Han T, Chen J, Hou C, Hua L, He S, et al. Clinical and Autoimmune Characteristics of Severe and Critical Cases of COVID-19. Clin Transl Sci. 2020;13(6):1077-1086. DOI: 10.1111/cts.12805
13. Dani M, Dirksen A, Taraborrelli P, Torocastro M, Panagopoulos D, Sutton R, et al. Autonomic dysfunction in 'long COVID': rationale, physiology and management strategies. Clin Med (Lond). 2021;21(1):e63-e67. DOI: 10.7861/clinmed.2020-0896
14. Østergaard L. SARS CoV-2 related microvascular damage and symptoms during and after COVID-19: Consequences of capillary transit-time changes, tissue hypoxia and inflammation. Physiol Rep. 2021;9(3):e14726. DOI: 10.14814/phy2.14726
15. Weng LM, Su X, Wang XQ. Pain Symptoms in Patients with Coronavirus Disease (COVID-19): A Literature Review. J Pain Res. 2021;14:147-159. DOI: 10.2147/JPR.S269206
16. Oronsky B, Larson C, Hammond TC, Oronsky A, Kesari S, Lybeck M, et al. A Review of Persistent Post-COVID Syndrome (PPCS). Clin Rev Allergy Immunol. 2023;64(1):66-74. DOI: 10.1007/s12016-021-08848-3
17. Walitt B, Bartrum E. A clinical primer for the expected and potential post-COVID-19 syndromes. Pain Rep. 2021;6(1):e887. DOI: 10.1097/PR9.0000000000000887
18. Marinangeli F, Giarratano A, Petrini F. Chronic pain and COVID-19: pathophysiological, clinical and organizational issues. Minerva Anestesiol. 2021;87(7):828-832. DOI: 10.23736/S0375-9393.20.15029-6
19. Agranovich N.V., Tkachenko L.I., Knyshova S.A., Titorenko M.V., Lichacheva A.P. Features of the course of new coronaviral infection (COVID-19) in patients with acute kidney injury and end stage renal failure. Nephrology (Saint-Petersburg). 2021;25(6):71-75. (In Russ.) DOI: 10.36485/1561-6274-2021-25-6-71-75
20. Galal I, Hussein AARM, Amin MT, Saad MM, Zayan HEE, Abdelsayed MZ, et al. Determinants of persistent post-COVID-19 symptoms: value of a novel COVID-19 symptom score. Egypt J Bronchol. 2021;15(1):10. DOI: 10.1186/s43168-020-00049-4
21. Carfì A, Bernabei R, Landi F; Gemelli Against COVID-19 Post-Acute Care Study Group. Persistent Symptoms in Patients After Acute COVID-19. JAMA. 2020;324(6):603-605. DOI: 10.1001/jama.2020.12603
22. Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020;382(18):1708-1720. DOI: 10.1056/NEJMoa2002032
23. Friedman N, Alter H, Hindiyeh M, Mendelson E, Shemer Avni Y, Mandelboim M. Human Coronavirus Infections in Israel: Epidemiology, Clinical Symptoms and Summer Seasonality of HCoV-HKU1. Viruses. 2018;10(10):515. DOI: 10.3390/v10100515
24. Christian MD, Poutanen SM, Loutfy MR, Muller MP, Low DE. Severe acute respiratory syndrome. Clin Infect Dis. 2004;38(10):1420-1427. DOI: 10.1086/420743
25. Li S, Wang R, Zhang Y, Zhang X, Layon AJ, Li Y, et al. Symptom combinations associated with outcome and therapeutic effects in a cohort of cases with SARS. Am J Chin Med. 2006;34(6):937-947. DOI: 10.1142/S0192415X06004417
26. Karateev A.E., Amirdzhanova V.N., Nasonov E.L., Lila A.M., Alekseeva L.I., Pogozheva E.Yu., et al. “Post-COVID syndrome”: The focus is on musculoskeletal pain. Rheumatology Science and Practice. 2021;59(3):255-262. (In Russ.) DOI: 10.47360/1995-4484-2021-255-262.
27. Halpin SJ, McIvor C, Whyatt G, Adams A, Harvey O, McLean L, et al. Postdischarge symptoms and rehabilitation needs in survivors of COVID-19 infection: A cross-sectional evaluation. J Med Virol. 2021;93(2):1013-1022. DOI: 10.1002/jmv.26368
28. Shostak N.A., Klimenko A.A., Demidova N.A., Kondrashov A.A., Andryashkina D.Y., Saakyan Y.M., et al. Musculoskeletal manifectations of the new coronavirus infection: focus on arthralgia and myalgia. The Clinician. 2021;15(1-4):31-41. DOI: 10.17650/1818-8338-2021-15-1-4-K650
29. Jacobs LG, Gourna Paleoudis E, Lesky-Di Bari D, Nyirenda T, Friedman T, Gupta A, et al. Persistence of symptoms and quality of life at 35 days after hospitalization for COVID-19 infection. PLoS One. 2020;15(12):e0243882. DOI: 10.1371/journal.pone.0243882
30. Soares FHC, Kubota GT, Fernandes AM, Hojo B, Couras C, Costa BV, et al. Prevalence and characteristics of new-onset pain in COVID-19 survivours, a controlled study. Eur J Pain. 2021;25(6):1342-1354. DOI: 10.1002/ejp.1755
31. Kemp HI, Corner E, Colvin LA. Chronic pain after COVID-19: implications for rehabilitation. Br J Anaesth. 2020;125(4):436-440. DOI: 10.1016/j.bja.2020.05.021
32. Memish ZA, Perlman S, Van Kerkhove MD, Zumla A. Middle East respiratory syndrome. Lancet. 2020;395(10229):1063-1077. DOI: 10.1016/S0140-6736(19)33221-0
33. Murat S, Dogruoz Karatekin B, Icagasioglu A, Ulasoglu C, İçten S, Incealtin O. Clinical presentations of pain in patients with COVID-19 infection. Ir J Med Sci. 2021;190(3):913-917. DOI: 10.1007/s11845-020-02433-x
34. Yomogida K, Zhu S, Rubino F, Figueroa W, Balanji N, Holman E. Post-Acute Sequelae of SARS-CoV-2 Infection Among Adults Aged ≥18 Years - Long Beach, California, April 1-December 10, 2020. MMWR Morb Mortal Wkly Rep. 2021;70(37):1274-1277. Erratum in: MMWR Morb Mortal Wkly Rep. 2021;70(39):1390. DOI: 10.15585/mmwr.mm7037a2.
35. Wostyn P. COVID-19 and chronic fatigue syndrome: Is the worst yet to come? Med Hypotheses. 2021;146:110469. DOI: 10.1016/j.mehy.2020.110469
36. Gasparotto M, Framba V, Piovella C, Doria A, Iaccarino L. Post-COVID-19 arthritis: a case report and literature review. Clin Rheumatol. 2021;40(8):3357-3362. DOI: 10.1007/s10067-020-05550-1
37. Karateev A.E., Lila A.M., Alekseeva L.I. Chronic Musculoskeletal Pain Associated with a Previous SARS-CoV-2 Infection. Doctor.Ru. 2021;20(7):7–11. (in Russ.) DOI: 10.31550/1727-2378-2021-20-7-7-11).
38. Hoong CWS, Amin MNME, Tan TC, Lee JE. Viral arthralgia a new manifestation of COVID-19 infection? A cohort study of COVID-19-associated musculoskeletal symptoms. Int J Infect Dis. 2021;104:363-369. DOI: 10.1016/j.ijid.2021.01.031
39. Manjavachi MN, Motta EM, Marotta DM, Leite DFP, Calixto JB. Mechanisms involved in IL-6-induced muscular mechanical hyperalgesia in mice. Pain. 2010;151(2):345-355. DOI: 10.1016/j.pain.2010.07.018
40. Saricaoglu EM, Hasanoglu I, Guner R. The first reactive arthritis case associated with COVID-19. J Med Virol. 2021;93(1):192-193. DOI: 10.1002/jmv.26296
41. Wu Z, Malihi Z, Stewart AW, Lawes CM, Scragg R. The association between vitamin D concentration and pain: a systematic review and meta-analysis. Public Health Nutr. 2018;21(11):2022-2037. DOI: 10.1017/S1368980018000551
42. Hasan LK, Deadwiler B, Haratian A, Bolia IK, Weber AE, Petrigliano FA. Effects of COVID-19 on the Musculoskeletal System: Clinician's Guide. Orthop Res Rev. 2021;13:141-150. DOI: 10.2147/ORR.S321884
43. Michalska-Kasiczak M, Sahebkar A, Mikhailidis DP, Rysz J, Muntner P, Toth PP, et al. Analysis of vitamin D levels in patients with and without statin-associated myalgia - a systematic review and meta-analysis of 7 studies with 2420 patients. Int J Cardiol. 2015;178:111-116. DOI: 10.1016/j.ijcard.2014.10.118
44. Agranovich N. V., Anopchenko A. S., Agranovich O. V., Aleksandrova O. A., Knyshova S. A., Kharchenko T. V. The articular syndrome: modern problems of diagnostics and treatment in the post-coronavirus period. Journal of young scientists. 2023;12(3):126-130.
Review
For citations:
Agranovich V.O., Gevandova M.G., Khripunova A.A., Agranovich N.V., Khodzhayan A.B., Anopchenko A.S. Post-covid muscle and joint syndrome: analysis of prevalence and clinical characteristics in the population of the North Caucasus federal district. South Russian Journal of Therapeutic Practice. 2026;7(1):87-96. (In Russ.) https://doi.org/10.21886/2712-8156-2026-7-1-87-96
Views:
318
JATS XML
Email this article 